These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 32643976

  • 1. Sustained Remission with Tocilizumab in Refractory Relapsing Polychondritis with Ocular Involvement: A Case Series.
    Farhat R, Clavel G, Villeneuve D, Abdelmassih Y, Sahyoun M, Gabison E, Sené T, Cochereau I, Titah C.
    Ocul Immunol Inflamm; 2021 Jan 02; 29(1):9-13. PubMed ID: 32643976
    [Abstract] [Full Text] [Related]

  • 2. Tocilizumab in Recalcitrant Bilateral Scleritis in a Case of Relapsing Polychondritis: A 17-year Follow Up.
    Doctor M, Murthy SI, Rajasekhar L.
    Ocul Immunol Inflamm; 2023 May 02; 31(4):870-873. PubMed ID: 35695904
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment with tocilizumab for refractory scleritis associated with relapsing polychondritis.
    Shimizu H, Nishioka H.
    Scand J Rheumatol; 2017 Sep 02; 46(5):418-419. PubMed ID: 28120637
    [No Abstract] [Full Text] [Related]

  • 4. Infliximab in a patient with refractory necrotizing scleritis associated with relapsing polychondritis.
    Jabbarvand M, Fard MA.
    Ocul Immunol Inflamm; 2010 Jun 02; 18(3):216-7. PubMed ID: 20482401
    [Abstract] [Full Text] [Related]

  • 5. Hypopyon uveitis and relapsing polychondritis: a report of 2 patients and review of autoimmune hypopyon uveitis.
    Anderson NG, Garcia-Valenzuela E, Martin DF.
    Ophthalmology; 2004 Jun 02; 111(6):1251-4. PubMed ID: 15177981
    [Abstract] [Full Text] [Related]

  • 6. Sustained response to tocilizumab in a patient with relapsing polychondritis complicated by aortitis.
    Sallés M, Mínguez S, Ros S, Tuneu R, Gelman SM.
    Clin Exp Rheumatol; 2017 Jun 02; 35 Suppl 103(1):223. PubMed ID: 28229816
    [No Abstract] [Full Text] [Related]

  • 7. [Isolated ocular recurrence of relapsing polychondritis. Apropos of a case].
    Gatinel D, Larroche C, Chaine G, Poulet B, Guillevin L.
    J Fr Ophtalmol; 1996 Jun 02; 19(2):153-7. PubMed ID: 8731786
    [Abstract] [Full Text] [Related]

  • 8. [Sustained response with tocilizumab in a case of refractory relapsing polychondritis].
    Weber E, Gaultier JB, Paul S, Guichard I, Monard E, Cathébras P.
    Rev Med Interne; 2014 Mar 02; 35(3):196-8. PubMed ID: 24074969
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of tocilizumab for psychiatric symptoms associated with relapsing polychondritis: the first case report and review of the literature.
    Liu L, Liu S, Guan W, Zhang L.
    Rheumatol Int; 2016 Aug 02; 36(8):1185-9. PubMed ID: 27260262
    [Abstract] [Full Text] [Related]

  • 10. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.
    Silpa-Archa S, Oray M, Preble JM, Foster CS.
    Acta Ophthalmol; 2016 Sep 02; 94(6):e400-6. PubMed ID: 27010181
    [Abstract] [Full Text] [Related]

  • 11. The ocular manifestations of relapsing polychondritis.
    Gallagher K, Al-Janabi A, Wang A.
    Int Ophthalmol; 2023 Aug 02; 43(8):2633-2641. PubMed ID: 36856986
    [Abstract] [Full Text] [Related]

  • 12. Tocilizumab for refractory relapsing polychondritis-long-term response monitoring by magnetic resonance imaging.
    Henes JC, Xenitidis T, Horger M.
    Joint Bone Spine; 2016 May 02; 83(3):365-6. PubMed ID: 26750763
    [No Abstract] [Full Text] [Related]

  • 13. Hypopyon uveitis (without scleritis) a manifestation symptom of relapsing polychondritis.
    Genevois O, Calenda E, Nasser Z, Benzerroug M, Gardea E, Muraine M.
    Ann Ophthalmol (Skokie); 2009 May 02; 41(3-4):208-11. PubMed ID: 20214060
    [Abstract] [Full Text] [Related]

  • 14. Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review.
    Stael R, Smith V, Wittoek R, Creytens D, Mielants H.
    Clin Rheumatol; 2015 Jan 02; 34(1):189-93. PubMed ID: 24831688
    [Abstract] [Full Text] [Related]

  • 15. Ocular inflammation associated with relapsing polychondritis in Japanese patients: a review of 11 patients.
    Tanaka R, Kaburaki T, Nakahara H, Komae K.
    Int Ophthalmol; 2019 Nov 02; 39(11):2649-2659. PubMed ID: 31077023
    [Abstract] [Full Text] [Related]

  • 16. Clinical features of Chinese patients with relapsing polychondritis.
    Yang P, Yuan W, Du L, Zhou Q, Wang C, Ye Z, Kijlstra A.
    Br J Ophthalmol; 2019 Aug 02; 103(8):1129-1132. PubMed ID: 30315131
    [Abstract] [Full Text] [Related]

  • 17. Successful Tocilizumab Treatment for Scleritis.
    Poelman HJ, Van Daele PLA, Rothova A.
    Ocul Immunol Inflamm; 2020 Aug 02; 28(2):285-287. PubMed ID: 31411511
    [Abstract] [Full Text] [Related]

  • 18. Scleritis in relapsing polychondritis. Response to therapy.
    Hoang-Xaun T, Foster CS, Rice BA.
    Ophthalmology; 1990 Jul 02; 97(7):892-8. PubMed ID: 2381703
    [Abstract] [Full Text] [Related]

  • 19. Scleritis associated with relapsing polychondritis.
    Sainz-de-la-Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS.
    Br J Ophthalmol; 2016 Sep 02; 100(9):1290-4. PubMed ID: 26888976
    [Abstract] [Full Text] [Related]

  • 20. Azathioprine as monotherapy for scleritis in relapsing polychondritis.
    Mellado F, Talesnik E, Castiglione E.
    Ocul Immunol Inflamm; 2012 Jun 02; 20(3):235-6. PubMed ID: 22449393
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.